The global aesthetic medicine market size is expected to reach USD 149.06 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data. Increasing inclination toward enhancing facial and bodily aesthetic appearance along with advancements in surgical as well as non-surgical aesthetic treatments is driving aesthetic...

The Enzyme inhibitors Market 2026 report provides detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Enzyme inhibitors market players, value chain optimization, trade regulations, recent developments, opportunities analysis,...

Peptide therapeutics, a class of drugs composed of short chains of amino acids, have emerged as a promising approach to treat various diseases, from metabolic disorders to cancer. These therapeutics leverage the specificity and effectiveness of peptides to target biological systems with minimal side effects. As the global healthcare landscape evolves, the peptide therapeutics market is poised...

The Peptide Therapeutics Market in 2023 is US$ 44.79 billion, and is expected to reach US$ 74.24 billion by 2031 at a CAGR of 6.50%. FutureWise Research published a report that analyzes Peptide Therapeutics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market...

The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides have gained a wide range of applications in medicine and biotechnology. In the last five years (2015–2019), the US Food Drug Administration (FDA) has authorized a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules, which...